In addition, exploring glycosylation of tumor cells in body fluids, namely STn expression, will offer a more selective malignant cell isolation, paving the way to downstream molecular analysis and fostering precision medicine applications in bladder cancer and other malignancies. This evidence concerns the gene EEF1A2 and urinary bladder carcinoma.